Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to... see more

TSXV:SBM - Post Discussion

Sirona Biochem Corp > New Press Release - Sirona Biochem Announces Payment of Convertible Debenture Interests in Shares
View:
Comment by Pandora on Oct 20, 2023 5:02pm
Is that what you describe as a "Friday after the market is closed" type of news release?
Comment by moneycollector on Oct 20, 2023 5:31pm
Can you see the smile in my face?
Comment by Pandora on Oct 20, 2023 6:15pm
It was in the news release back in April: "The Principal of the Debenture Units will accrue interest at a rate of 12% per annum, which accrued interest (“Accrued Interest”) will be paid semi-annually, in arrears. The Company will pay the Prepaid Interest and Accrued Interest in cash or, subject to TSX Venture Exchange (“TSXV”) acceptance, may elect to satisfy payment in kind by issuing ...more  
Comment by lscfa on Oct 20, 2023 11:40pm
No way these bozos voluntarily agreed to an upfront payment of only $500,000 US.
Comment by MirrorWorldMan on Oct 21, 2023 1:00am
Howie has no money anymore and has to pay loan interest with all time low shares. Dismal. So much for non diluted financing. These guys are worthless. 
Comment by Pareto8020 on Oct 21, 2023 9:41am
Can't wait to see how biorun spins this as a positive?   At every turn Howard makes the wrong decision and guides this ship onto the rocks.  Let us look at some highlights.....  - Partnering up with Wanbang..... they slow walk SGLT2 trial and it goes generic in China and trial has to be discontinued.  Then they continue the partnership and the information Wanbang is ...more  
Comment by tylerreddick on Oct 21, 2023 10:41am
" The Company will issue an aggregate of [1,380,979] Common Shares at $[0.0675][based on closing price of $0.09 on October 19, 2023 with 25% maximum discounted applied] " Up yours, Howie.
Comment by biorun on Oct 21, 2023 2:44pm
I don't see this actual transaction disclosure as positive or negative. This information on the option was disclosed prior.  What pisses me off is when they fart around with the news flow which creates opportunity for them. We will only ever know if that is the case after the fact. Who do you think will be one of the main participants in the next raise? Yes, you guessed it, Howard. The ...more  
Comment by tylerreddick on Oct 21, 2023 5:09pm
So you are saying that they illegally manipulate the release of news in order to push the share price down when they want to accumulate? Interesting accusation.
Comment by biorun on Oct 21, 2023 10:45pm
Not exactly but we need to watch this space moving forward. How many times have we seen 1. Dead silence which results in a steady slide as we all start to wonder, then 2. Crappy financials, then 3. Private placement at crappy prices, then 3-6 months later all of sudden fantastic news that doubled, tripled or quadrupled the stock? Look at the historical low points then look what happens 12 months ...more  
Comment by tylerreddick on Oct 22, 2023 7:22am
The science is worthless unless they can produce a product, and so far Howie has failed spectacularly at that objective. If Abbvie ever actually does something, then and only then can we celebrate. Otherwise we may need to get the lawyers involved.
Comment by lscfa on Oct 22, 2023 12:01pm
Mgmt silence on the Abbvie deal is stupidly excessive. Michelle told me that the deal does contain performance clauses where Abbvie must commercialize within a certain period or lose exclusivity. Sirona should have at least disclosed this so investors don't think that Abbvie can sit on this for ever and not produce anything.    
Comment by tylerreddick on Oct 22, 2023 10:10pm
Selective disclosure is even worse. But nothing new for Vulture stocks. But I don't see why Abbvie wouldn't at least make some attempt, no matter how pathetic, to try to get a product out there. Unless there remains some problem that management has been hiding?
Comment by Turtle4 on Oct 23, 2023 7:48am
Please do not post contract information. There can be heavy penalties for Michelle and sirona if allergan gets this out. I think it has its reasons why Michelle was terminated....
Comment by tylerreddick on Oct 23, 2023 8:54am
Maybe if Howie would tell the owners of SBM, THE SHAREHOLDERS, what the heck was going on, there wouldn't be any issues? This garbage about "confidential" contract detail has to stop. We have a right to know, and when we are kept in the dark, have little choice but to assume we are being lied to. JMO
Comment by biorun on Oct 23, 2023 10:02am
i dont think anyone here is looking to either compromise the contract agreement or seek details about the agreement that are not available to share. Having a non compliance clause in an agreement such as this one is quite standard, so lets not get dramatic here. We are simply wanting a little more information than "we can say due to confidentiality reasons", and for us to know that 1 ...more  
Comment by tylerreddick on Oct 23, 2023 11:32am
And yet all we get from Howie is crickets. One has to wonder if he can't find a single positive thing to say, maybe there is nothing but bad news coming?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities